BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Trindade AJ, McKinley MJ, Alshelleh M, Levi G, Stewart M, Quinn KJ, Thomas RM. Mutational load may predict risk of progression in patients with Barrett's oesophagus and indefinite for dysplasia: a pilot study. BMJ Open Gastroenterol 2019;6:e000268. [PMID: 30815274 DOI: 10.1136/bmjgast-2018-000268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Kamboj AK, Leggett CL. Barrett's esophagus indefinite for dysplasia carries a definite risk of neoplasia. Gastrointest Endosc 2021;94:271-2. [PMID: 33975711 DOI: 10.1016/j.gie.2021.03.019] [Reference Citation Analysis]
2 Watts AE, Cotton CC, Shaheen NJ. Radiofrequency Ablation of Barrett's Esophagus: Have We Gone Too Far, or Not Far Enough? Curr Gastroenterol Rep 2020;22:29. [PMID: 32383077 DOI: 10.1007/s11894-020-00766-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Mittal SK, Abdo J, Adrien MP, Bayu BA, Kline JR, Sullivan MM, Agrawal DK. Current state of prognostication, therapy and prospective innovations for Barrett's-related esophageal adenocarcinoma: a literature review. J Gastrointest Oncol 2021;12:1197-214. [PMID: 34532080 DOI: 10.21037/jgo-21-117] [Reference Citation Analysis]
4 Choi WT, Lauwers GY, Montgomery EA. Utility of ancillary studies in the diagnosis and risk assessment of Barrett's esophagus and dysplasia. Mod Pathol 2022. [PMID: 35260826 DOI: 10.1038/s41379-022-01056-0] [Reference Citation Analysis]